Apex Capital Management’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$43.4M Buy
562,997
+40,900
+8% +$2.64M 0.96% 41
2015
Q4
$33.3M Buy
522,097
+5,206
+1% +$336K 0.74% 57
2015
Q3
$34.6M Buy
516,891
+155,044
+43% +$11M 0.78% 56
2015
Q2
$24.4M Buy
361,847
+27,336
+8% +$1.93M 0.52% 69
2015
Q1
$23.4M Buy
334,511
+43,020
+15% +$2.91M 0.55% 65
2014
Q4
$19.6M Buy
291,491
+39,939
+16% +$2.63M 0.52% 69
2014
Q3
$17.4M Buy
251,552
+17,116
+7% +$1.34M 0.52% 69
2014
Q2
$19.2M Buy
+234,436
New +$15.9M 0.59% 68

Other funds holding PRLB

Apex Capital Management's PRLB Position: Q1 2016 in Review

Apex Capital Management increased its Protolabs (PRLB) stake by 7.8% in Q1 2016, buying an estimated $2.64M and bringing the position to 562,997 shares worth $43.4M. The position accounts for 0.96% of the portfolio, ranked #41.

Apex Capital Management first reported a position in PRLB in Q2 2014 and has held it in 8 quarters since. 212 funds tracked by Wall St. Rank hold PRLB as of Q1 2016.

  • Apex Capital Management held 562,997 shares of Protolabs worth $43.4M as of Q1 2016.
  • Apex Capital Management bought 40,900 Protolabs shares in Q1 2016, an estimated $2.64M.
  • Protolabs made up 0.96% of Apex Capital Management's portfolio in Q1 2016, its #41 holding.
  • Apex Capital Management first reported a position in Protolabs in Q2 2014 and has held it in 8 quarters since.
  • 212 funds tracked by Wall St. Rank held Protolabs as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.